1. Home
  2. MTEM vs HUGE Comparison

MTEM vs HUGE Comparison

Compare MTEM & HUGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MTEM
  • HUGE
  • Stock Information
  • Founded
  • MTEM N/A
  • HUGE 1998
  • Country
  • MTEM United States
  • HUGE Canada
  • Employees
  • MTEM N/A
  • HUGE N/A
  • Industry
  • MTEM Biotechnology: Biological Products (No Diagnostic Substances)
  • HUGE Biotechnology: Pharmaceutical Preparations
  • Sector
  • MTEM Health Care
  • HUGE Health Care
  • Exchange
  • MTEM Nasdaq
  • HUGE Nasdaq
  • Market Cap
  • MTEM 8.5M
  • HUGE 7.8M
  • IPO Year
  • MTEM N/A
  • HUGE N/A
  • Fundamental
  • Price
  • MTEM $1.36
  • HUGE $0.15
  • Analyst Decision
  • MTEM
  • HUGE
  • Analyst Count
  • MTEM 0
  • HUGE 0
  • Target Price
  • MTEM N/A
  • HUGE N/A
  • AVG Volume (30 Days)
  • MTEM 19.6K
  • HUGE 2.6M
  • Earning Date
  • MTEM 08-08-2024
  • HUGE 09-12-2024
  • Dividend Yield
  • MTEM N/A
  • HUGE N/A
  • EPS Growth
  • MTEM N/A
  • HUGE N/A
  • EPS
  • MTEM N/A
  • HUGE N/A
  • Revenue
  • MTEM $31,763,000.00
  • HUGE N/A
  • Revenue This Year
  • MTEM N/A
  • HUGE N/A
  • Revenue Next Year
  • MTEM N/A
  • HUGE N/A
  • P/E Ratio
  • MTEM N/A
  • HUGE N/A
  • Revenue Growth
  • MTEM N/A
  • HUGE N/A
  • 52 Week Low
  • MTEM $1.01
  • HUGE $0.13
  • 52 Week High
  • MTEM $9.45
  • HUGE $1.68
  • Technical
  • Relative Strength Index (RSI)
  • MTEM 54.29
  • HUGE 38.67
  • Support Level
  • MTEM $1.26
  • HUGE $0.14
  • Resistance Level
  • MTEM $1.50
  • HUGE $0.16
  • Average True Range (ATR)
  • MTEM 0.11
  • HUGE 0.01
  • MACD
  • MTEM 0.01
  • HUGE 0.01
  • Stochastic Oscillator
  • MTEM 62.16
  • HUGE 58.97

About MTEM Molecular Templates Inc.

Molecular Templates Inc is a clinical-stage biopharmaceutical company focused on developing therapeutic agents that selectively target tumor cells for the treatment of individuals living with cancer. Its pipeline products are MT-6402, MT-8421 and MT-0169.

About HUGE FSD Pharma Inc. Class B Subordinate Voting Shares

FSD Pharma Inc is a biopharmaceutical company developing three clinical candidates with the potential to address neuropsychiatric, neurodegenerative, and inflammatory disorders. Along with its subsidiaries, the group is focused on pharmaceutical research and development of its compound, FSD201, an ultra-micronized PEA, for the treatment of inflammatory diseases; Lucid-Psych is used in the treatment of mental health disorders and Lucid-MS is used in the treatment of neurodegenerative disorders. The company operates in two segments: Biopharmaceutical and Strategic Investments.

Share on Social Networks: